Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Mar;41(3):388-91.
doi: 10.1097/00007890-198603000-00021.

Cyclosporine metabolism and pharmacokinetics following intravenous and oral administration in the dog

Cyclosporine metabolism and pharmacokinetics following intravenous and oral administration in the dog

B Gridelli et al. Transplantation. 1986 Mar.

Abstract

The influence of assay method on single dose cyclosporine (CsA) pharmacokinetics was studied in nine dogs receiving either i.v. or oral CsA. Samples were drawn from hepatic, portal, and systemic veins at various times after the dose and CsA levels were determined by radioimmunoassay (RIA) and high-performance liquid chromatography (HPLC). Blood concentration-time data were analyzed by nonlinear least-squares regression, using two-compartment models. RIA/HPLC ratios for all samples were greater than one, and did not change significantly over time. The mean RIA/HPLC ratios for samples drawn from all three veins were higher after oral than i.v. doses of the drug (P less than 0.05). Area under the concentration-time curve (AUC) was higher and systemic clearance (CIs) lower than calculated on the basis of RIA results, regardless of the route of administration. AUC calculated for CsA metabolites (RIA-HPLC) was highest in the portal vein after an oral dose of CsA. Bioavailability was 20.4% and 27.0% when estimated using HPLC and RIA data, respectively. The mean CsA metabolite index (CMI), when calculated for hepatic, portal, or systemic vein, was greater when the drug was administered orally. The mean hepatic extraction ratio (HER) of the parent drug and for CsA metabolites was approximately 23% in i.v. and p.o. studies. These results suggest that the gastrointestinal tract may play a role in the metabolism of CsA when the drug is administered orally. In addition, if CsA metabolites not measured by HPLC have either toxic or immunosuppressive properties, the RIA assay may be more useful for monitoring patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean hepatic vein CsA blood concentration after i.v. administration of 5 mg/kg CsA. Each point is the mean of CsA determinations in five animals, with bars indicating standard error. (– –○– –) RIA determinations (– –●––) HPLC determination.
Figure 2
Figure 2
Mean hepatic vein CsA blood concentration was determined at various times after p.o. administration of 17.5 mg/kg CsA. Bars indicate standard error of the mean of four values (– –○– –) RIA determination; (– –●– –)HPLC determination.

Similar articles

Cited by

References

    1. Elliott JF, Lin Y, Mizel SB, Bleackley RC, Harnish DG, Paetkan V. Induction of Interleukin 2 messenger RNA inhibited by cyclosporin A. Science. 1984;226:1439. - PubMed
    1. Starzl TE. Clinical aspects of cyclosporine therapy: a summation. Transplant Proc. 1982;14(suppl 1):3103. - PMC - PubMed
    1. Britton S, Palacios R. Cyclosporin A: Usefulness, risks and mechanism of action. Immunol Rev. 1982;65:5. - PubMed
    1. Kahan BD, Ried M, Newburger J. Pharmacokinetics of cyclosporine in human renal transplantation. Transplant Proc. 1983;15:446.
    1. Kekown PA, Stiller CR, Laupacis AL, et al. The effects and side effects of cyclosporine: relationship to drug pharmacokinetics. Transplant Proc. 1983;14:659. - PubMed

Publication types